Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: A randomized, double-blind, crossover trial

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 4, 2006, Pages 1317-1322

  Nielsen, Viveque Egsgaard ^a   Bonnema, Steen J ^a   Hegedüs, Laszlo ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROTROPIN; RECOMBINANT PROTEIN; THYROXINE;

ARTICLE; CERVICOBRACHIAL NEURALGIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; GOITER; HUMAN; HYPERTHYROIDISM; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; THYROID FUNCTION; THYROID GLAND; ADULT; AGED; BLOOD; CHEMICALLY INDUCED DISORDER; ECHOGRAPHY; FEMALE; MALE; MIDDLE AGED; NODULAR GOITER; PATHOLOGY; PATHOPHYSIOLOGY; THYROID FUNCTION TEST;

ADULT; AGED; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GOITER, NODULAR; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; THYROID FUNCTION TESTS; THYROID GLAND; THYROTROPIN; THYROXINE;

EID: 33646042578     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2137     Document Type: Article

References (21)

1. Danowski TS, Mateer FM, Weigle WO, Borecky DC, Moses C 1960 Thyroiditis following administration of thyroid-stimulating hormone. J Clin Endocrinol Metab 20:1521-1525
2. Braga M, Ringel MD, Cooper DS 2001 Sudden enlargement of local recurrent thyroid tumor after recombinant human TSH administration. J Clin Endocrinol Metab 86:5148-5151
3. Giovanni V, Arianna LG, Antonio C, Francesco F, Michele K, Giovanni S, Marco S, Giovanni L 2002 The use of recombinant human TSH in the follow-up of differentiated thyroid cancer: experience from a large patient cohort in a single centre. Clin Endocrinol (Oxf) 56:247-252
4. Goffman T, Loffe V, Tuttle M, Bowers JT, Mason ME 2003 Near-lethal respiratory failure after recombinant human thyroid stimulating hormone use in a patient with metastatic thyroid carcinoma. Thyroid 13:827-830
5. Robbins RJ, Voelker E, Wang W, Macapinlac HA, Larson SM 2000 Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: case report and review of literature. Endocr Pract 6:460-464
6. Nielsen VE, Bonnema SJ, Hegedüs L 2004 Effects of recombinant human TSH on thyroid size and function, in normal subjects. A randomized double-blind cross-over trial. J Clin Endocrinol Metab 89:2242-2247
7. Nieuwlaat WA, Hermus AR, Ross HA, Buijs WC, Edelbroek MA, Bus JW, Corstens FH, Huysmans DA 2004 Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone. J Nucl Med 45:626-633
8. Albino CC, Mesa Jr CO, Olandoski M, Ueda E, Woellner LC, Goedert CA, Souza AM, Graf H 2005 Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine. J Clin Endocrinol Metab 90:2775-2780
9. Huysmans DA, Nieuwlaat WA, Erdtsieck RJ, Schellekens AP, Bus JW, Bravenboer B, Hermus AR 2000 Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter. J Clin Endocrinol Metab 85:3592-3596
10. Nielsen VE, Bonnema SJ, Boel-Jorgensen H, Veje A, Hegedüs L 2005 Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial. J Clin Endocrinol Metab 90:79-83
11. Torres MS, Ramirez L, Simkin PH, Braverman LE, Emerson CH 2001 Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects. J Clin Endocrinol Metab 86:1660-1664
12. Nielsen VE, Bonnema SJ, Hegedüs L 2004 The effects of recombinant human thyrotropin, in normal subjects and patients with goitre. Clin Endocrinol (Oxf) 61:655-663
13. Bonnema SJ, Bertelsen H, Mortensen J, Andersen PB, Knudsen DU, Bastholt L, Hegedüs L 1999 The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. J Clin Endocrinol Metab 84:3636-3641
14. Nygaard B, Faber J, Hegedüs L 1994 Acute changes in thyroid volume and function following 131I therapy of multinodular goitre. Clin Endocrinol (Oxf) 41:715-718
15. Hegedüs L, Bonnema SJ, Bennedbaek FN 2003 Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24:102-132
16. Nieuwlaat WA, Huysmans DA, van den Bosch HC, Sweep CG, Ross HA, Corstens FH, Hermus AR 2003 Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab 88:3121-3129
17. Hegedüs L, Perrild H, Poulsen LR, Andersen JR, Holm B, Schnohr P, Jensen G, Hansen JM 1983 The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J Clin Endocrinol Metab 56:260-263
18. Duick DS, Baskin HJ 2003 Utility of recombinant human thyrotropin for augmentation of radioiodine uptake and treatment of nontoxic and toxic multinodular goiters. Endocr Pract 9:204-209
19. Silva MNC, Rubio IGS, Romao R, Gebrin EMMS, Buchpiguel C, Tomimori E, Camargo R, Silvia M, Medeiros-Neto C, Medeiros-Neto G 2003 Administration of a single dose of recombinant human thyrotropin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres. Clin Endocrinol (Oxf) 59:1-9
20. Ramirez L, Braverman LE, White B, Emerson CH 1997 Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects. J Clin Endocrinol Metab 82:2836-2839
21. Gittoes NJ, Miller MR, Daykin J, Sheppard MC, Franklyn JA 1996 Upper airways obstruction in 153 consecutive patients presenting with thyroid enlargement. BMJ 312:484